506 related articles for article (PubMed ID: 6333948)
1. Prevention of immune precipitation by purified classical pathway complement components.
Naama JK; Hamilton AO; Yeung-Laiwah AC; Whaley K
Clin Exp Immunol; 1984 Nov; 58(2):486-92. PubMed ID: 6333948
[TBL] [Abstract][Full Text] [Related]
2. The role of C1, C1-inactivator and C4 in modulating immune precipitation.
Schifferli JA; Steiger G; Schapira M
Clin Exp Immunol; 1985 Jun; 60(3):605-12. PubMed ID: 4017288
[TBL] [Abstract][Full Text] [Related]
3. Prevention of immune precipitation by purified components of the alternative pathway.
Naama JK; Holme E; Hamilton E; Whaley K
Clin Exp Immunol; 1985 Apr; 60(1):169-77. PubMed ID: 3159522
[TBL] [Abstract][Full Text] [Related]
4. Complement-mediated inhibition of immune precipitation. I. Role of the classical and alternative pathways.
Schifferli JA; Woo P; Peters DK
Clin Exp Immunol; 1982 Mar; 47(3):555-62. PubMed ID: 6979442
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of immune precipitation by complement.
Hong K; Takata Y; Sayama K; Kozono H; Takeda J; Nakano Y; Kinoshita T; Inoue K
J Immunol; 1984 Sep; 133(3):1464-70. PubMed ID: 6747294
[TBL] [Abstract][Full Text] [Related]
6. Regulation of immune complex-mediated complement activation by autoantibodies (F-42) isolated from sera of patients with systemic lupus erythematosus.
Daha MR; Hazevoet HM; Vanes LA
Clin Exp Immunol; 1983 Sep; 53(3):541-6. PubMed ID: 6604604
[TBL] [Abstract][Full Text] [Related]
7. C1- inactivator: its efficiency as a regulator of classical complement pathway activation by soluble IgG aggregates.
Doekes G; van Es LA; Daha MR
Immunology; 1983 Jun; 49(2):215-22. PubMed ID: 6852866
[TBL] [Abstract][Full Text] [Related]
8. Activation of the first component of complement, C1, by a monoclonal antibody recognizing the C chain of C1q.
Heinz HP; Burger R; Golan MD; Loos M
J Immunol; 1984 Feb; 132(2):804-8. PubMed ID: 6606678
[TBL] [Abstract][Full Text] [Related]
9. The modulation of immune complex aggregation by classical pathway-mediated reactions.
Gronski P; Bodenbender L; Kanzy EJ; Loos M; Seiler FR
Immunobiology; 1985 May; 169(4):346-61. PubMed ID: 3874147
[TBL] [Abstract][Full Text] [Related]
10. Antibody-independent activation of C1. II. Evidence for two classes of nonimmune activators of the classical pathway of complement.
Peitsch MC; Kovacsovics TJ; Tschopp J; Isliker H
J Immunol; 1987 Mar; 138(6):1871-6. PubMed ID: 3029223
[TBL] [Abstract][Full Text] [Related]
11. Control of immune complexes by the classical pathway.
Whaley K; Ahmed AE
Behring Inst Mitt; 1989 Jul; (84):111-20. PubMed ID: 2529842
[TBL] [Abstract][Full Text] [Related]
12. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
Brown EJ; Ramsey J; Hammer CH; Frank MM
J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
[TBL] [Abstract][Full Text] [Related]
13. Control of C1 activation by nascent C3b and C4b: a mechanism of feedback inhibition.
Ziccardi RJ
J Immunol; 1986 May; 136(9):3378-83. PubMed ID: 3485688
[TBL] [Abstract][Full Text] [Related]
14. Depressed classical complement pathway activities in chronic lymphocytic leukaemia.
Füst G; Czink E; Minh D; Miszlay Z; Varga L; Hollán SR
Clin Exp Immunol; 1985 Jun; 60(3):489-95. PubMed ID: 4017286
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of C3 deposition on solid-phase bound immune complexes by lactoferrin.
Kievits F; Kijlstra A
Immunology; 1985 Mar; 54(3):449-56. PubMed ID: 3844370
[TBL] [Abstract][Full Text] [Related]
16. Studies on the haemolytic activity of circulating C1q-C3/C4 complexes.
Wouters D; Brouwer MC; Daha MR; Hack CE
Mol Immunol; 2008 Apr; 45(7):1893-9. PubMed ID: 18054386
[TBL] [Abstract][Full Text] [Related]
17. Effect of plicatic acid on human serum complement includes interference with C1 inhibitor function.
Giclas PC
J Immunol; 1982 Jul; 129(1):168-72. PubMed ID: 6979566
[TBL] [Abstract][Full Text] [Related]
18. Immune complex mediated activation of the classical complement pathway.
Borsos T
Behring Inst Mitt; 1989 Jul; (84):93-101. PubMed ID: 2478118
[TBL] [Abstract][Full Text] [Related]
19. Activation of the first component of human complement, C1, by monoclonal antibodies directed against different domains of subcomponent C1q.
Kilchherr E; Schumaker VN; Phillips ML; Curtiss LK
J Immunol; 1986 Jul; 137(1):255-62. PubMed ID: 3486914
[TBL] [Abstract][Full Text] [Related]
20. Complement activation and impaired capacity to solubilize immune complexes or to prevent their formation in essential mixed cryoglobulinemia.
Corvetta A; Spaeth PJ; Ghirelli PA; Orecchioni F; Buetler R; Montroni M; Nydegger UE
Diagn Immunol; 1983; 1(4):315-23. PubMed ID: 6333960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]